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What is known about the subject?
 ► Infants born very preterm are at increased risk of 
developing neuropsychiatric conditions such as 
attention- deficit hyperactivity disorder and autism 
spectrum disorder.
 ► A large number of genetic risk variants have been 
identified for neuropsychiatric disorders.
What this study adds?
 ► A large- scale efficient and cost- effective cohort 
study of preterm infants for genetic investigations in 
the UK is feasible.
 ► Longitudinal health and education outcome ascer-
tainment of very preterm infants through routine 
data linkage are acceptable to parents.
ABSTRACT
Background Genetic risk variants and preterm birth 
are early and potent risk factors for later neuropsychiatric 
disorders. To understand the interrelationships between 
these factors, a large- scale genetic study of very preterm 
(VPT, <32 weeks gestation) infants with prospective 
follow- up is required. In this paper, we describe a 
streamlined study approach, using efficient processes for 
biological and clinical data collection, to feasibly establish 
such a cohort.
Methods We sought to recruit 500 VPT families within a 
1 year period from neonatal units. Treating clinical teams 
recruited eligible participants, obtained parent consent, 
collected blood samples and posted specimens to the 
research laboratory. We extracted all clinical data from 
the National Neonatal Research Database, an existing UK 
resource that captures daily patient- level data on all VPT 
infants.
Results Between May 2017 and June 2018, we 
established a cohort of 848 VPT infants and their parents 
from 60 English neonatal units. The study population 
(median (IQR), gestation: 28.9 (26–30) weeks; birth weight: 
1120 (886–1420) g) represented 18.9% of eligible infants 
born at the study sites during the recruitment period 
(n=4491). From the subset of 521 complete family trios, 
we successfully completed genotyping for 510 (97.9%) 
trios. Of the original 883 infants whose parents consented 
to participate, the parents of 796 (90.1%) infants agreed to 
future data linkage and 794 (89.9%) agreed to be recalled.
Conclusion We demonstrate the feasibility and 
acceptability of streamlined strategies for genetic, neonatal 
and longitudinal data collection and provide a template for 
future cost- effective and efficient cohort development.
BACkgRound
Globally, approximately 15 million infants 
are born preterm (<37 weeks gestation) 
each year and the prevalence is rising.1 The 
causes of spontaneous preterm births and 
the conditions justifying ‘medically indicated’ 
preterm birth are complex and poorly under-
stood, with both environmental factors2 3 and 
genetic components4 implicated. Preterm 
infants experience significant adversities and 
are at elevated risk of intellectual disability, 
behavioural and mental health problems, 
with approximately a quarter of children 
born extremely preterm meeting neuropsy-
chiatric diagnostic criteria by childhood.5 
However, there is considerable heteroge-
neity in outcomes, the causes of which are 
unknown.
Previous epidemiological studies have 
suggested family and genetic factors may 
contribute to the link between preterm birth 
and later neuropsychiatric disorders. Many 
of these studies have observed an associa-
tion between maternal mental health prob-
lems and risk of preterm birth.6 7 Positive 
family history of psychiatric disorder further 
contributes to the risk of adverse mental 
health outcomes among individuals born 
preterm.8 9 Genomic studies have identified 
large numbers of genetic risk variants for 
major neuropsychiatric disorders, including 
those for attention- deficit hyperactivity 
disorder and autism spectrum disorder, which 
are the neuropsychiatric disorders most 
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strongly associated with preterm birth in childhood.10 
However, the relevance of these genetic risk variants for 
those born preterm has not been investigated.
A large preterm birth cohort with genomic data and 
prospective clinical phenotyping would be required 
to investigate the relationship between genetic risks, 
preterm birth and neuropsychiatric outcomes. There is 
no sufficiently powered existing prospective cohort of 
preterm infants for such investigations and the costs, 
time and resource requirements for recruitment and data 
collection by established methods are likely to be prohib-
itive. Our aims were to examine the feasibility of large- 
scale recruitment and DNA collection in a multicentre 
setting, by capitalising on existing research infrastructure 
in the UK to streamline operational efficiencies, and the 
acceptability to parents of prospective follow- up through 
routine data linkage and direct recall for detailed pheno-
typing. Our secondary aim was to conduct a prelimi-
nary investigation to explore the hypothesis that the 
very preterm (VPT, <32 weeks gestation) population is 
enriched for rare pathogenic copy number variants; the 
results of this investigation were reported in a separate 
paper.11
MeThodS
Study sites and recruitment
We invited expressions of interest in participation as study 
sites from all 43 neonatal intensive care units (NICUs) 
and 77 local neonatal units (LNUs) in England. In the 
UK, neonatal care is provided within managed clinical 
networks where LNUs provide the full range of care, 
including short periods of intensive care, for babies deliv-
ered in the nominal catchment area of the hospital.12 
Most babies born over 27 weeks gestation will usually 
receive their full care in their LNU. Babies who are more 
preterm or those who require complex or longer- term 
intensive care are transferred to a NICU, where tertiary 
specialist care is provided. From the units that expressed 
interest, we selected study sites based on the potential 
number of eligible participants, geographical coverage 
and record of accomplishment of research activities in 
the unit. The study was included in the National Insti-
tute for Health Research Clinical Research Network 
Portfolio, which allowed us to access support, such as 
Clinical Research Network- funded research nurses in 
England. Being a ‘portfolio study’ also acts as an incen-
tive for recruitment activities from neonatal units as the 
accrual data are used to inform future allocations of NHS 
research support funding to hospital trusts. All study 
procedures were carried out by the treating clinical or 
research staff based locally at the participating study sites. 
These local staff received training in the study proce-
dures from the investigator team using training videos 
and teleconferences.
Recruitment took place between 1 May 2017 and 30 
June 2018. Eligible participants were infants born VPT 
and their parents. While we aimed to recruit both parents 
for trio- based genome analysis, single- parent families were 
also included. Similarly, we recruited infants where one 
or both parents declined to participate in the study them-
selves. We did not recruit parents known to be genetically 
unrelated to the child, for instance if the pregnancy had 
arisen from a donor gamete. Potential participants could 
be approached and recruited at any point during their 
neonatal hospitalisation at the discretion of the local 
research staff. Informed written consent was obtained 
from each parent (for themselves) and their offspring at 
the local site. We sought to recruit 500 VPT infants over 
the 1 year recruitment phase.
Biological specimen collection and laboratory processing
Blood samples from participants were collected into 
EDTA specimen bottles. For infants, 0.5 to 1 mL of blood 
were collected by heel lance, venepuncture or from an 
indwelling arterial catheter during blood sampling for 
routine clinical care to avoid an additional intervention 
for the infant. If the target volume was not achieved, 
a second aliquot was obtained, also collected during 
routine sampling. Five millilitre of blood was collected 
from each parent. The blood specimens were labelled 
using barcodes and a unique participant study number, 
packaged in a designated mailing box for biological spec-
imens, in accordance with UN3373 regulations and P650 
packaging instructions, and posted to the research labo-
ratory at the MRC Centre for Neuropsychiatric Genetics 
and Genomics (MRC CNGG), Cardiff University within 
7 days of sample collection using UK standard postal 
services. No laboratory processing of the samples took 
place at the recruitment study sites.
DNA was extracted from the blood specimens in- house 
at the MRC CNGG, from full sets of parent–infant trios in 
the first instance, using GE Healthcare DNA extraction 
kits. DNA sample quantification was determined using 
Quant- iT PicoGreen dsDNA assay kits and samples 
were genotyped using Illumina OmniExpress BeadChip 
arrays. Samples with concentrations below 50 ng/μL 
were excluded from genotyping. DNA was considered of 
adequate quality on successful completion of array- based 
genotyping.
Clinical data collection
To minimise research workload and participant burden, 
we capitalised on the existing National Neonatal Research 
Database (NNRD) to access relevant clinical data on the 
research participants. Investigator NM led the establish-
ment of the NNRD in 2007 to support the use of clinical 
data to improve neonatal care and outcomes, and the UK 
Neonatal Collaborative comprising all neonatal units that 
contributed data. Patient- level point- of- care electronic 
data entered by treating clinicians on all infants admitted 
to the neonatal units are released with permission from 
the Caldicott Guardians to the Neonatal Data Analysis 
Unit at Imperial College London, where they are merged 
and cleaned to create the NNRD (https://www. imperial. 
ac. uk/ neonatal- data- analysis- unit). Data captured on the 
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NNRD include demographic details, daily records of 
intervention and treatments through the neonatal inpa-
tient stay, diagnoses and follow- up health status at age 
2 years. The NNRD has complete population coverage of 
all neonatal unit admissions, including all VPT births in 
England, Wales and Scotland (approximately 7000 annu-
ally) and is approved by the UK National Research Ethics 
Service (10/80803/151) as a research database and by 
the Health Research Authority Confidentiality Advisory 
Group (8-05(f)/0210).
On receipt of parent signed authorisation, the unique 
NNRD identifier for each participating infant was 
obtained from his/her neonatologist. All relevant partici-
pant clinical data, including gestational age, birth weight, 
sex, time of onset of labour and maternal postcode, were 
extracted from the NNRD.
Consent for follow-up
Permissions were sought from parents of participating 
infants to conduct follow- up studies by means of linkage 
of the genetic and clinical data to future routine health 
and educational records, in order to reduce the research 
burden associated with long- term follow- up and outcome 
ascertainment. This was indicated by the parents’ 
response to the following statement in the consent form: 
‘I give permission for the research team to link the study infor-
mation on my baby to records that the NHS and other public 
organisations hold’. Consent was also sought for recon-
tacting the family in the future for detailed phenotyping 
through face- to- face or questionnaire- based assessments.
Parents were made aware of their right to withdraw from 
the study at any point by contacting the researchers.
Patient and public involvement
We involved Bliss, the leading national preterm charity 
in the design and funding application for the study. We 
consulted parent representatives in developing the study 
materials including the participant information sheet. 
They will be consulted for the public dissemination of 
the findings from this research.
ReSulTS
Recruitment and establishment of study population
We received expressions of interest from 75 out of 120 
neonatal units in England. Of these, we selected 60 
neonatal units (24 NICUs and 36 LNUs) to be study 
sites. These provided an extensive population catchment 
coverage in England (see online supplementary mate-
rial 1 for geographical coverage and list of participating 
hospitals).
During the 14- month recruitment period, 1853 families 
were approached and 779 (42.0%) families, consisting 
of 883 infants, consented to participation (figure 1). 
Blood samples were not collected in nine infants prior to 
their discharge. In five cases, the sample was lost during 
postage. Blood samples from 869 infants, 753 mothers 
and 551 fathers were successfully received in the MRC 
CNGG laboratory. Of these samples, there were 529 full 
infant–parent trios, quads (in twin births) or quints (in 
triplet births).
Clinical data extraction from the NNRD was successful 
in 848 (97.6%) infants whose blood samples had arrived 
at the laboratory. The demographic and neonatal charac-
teristics of these participants are summarised in table 1.
During the recruitment period, a total of 8998 infants 
were born at <32 weeks gestation in England, with 4491 
being born at participating study sites. Therefore, this 
study cohort represent 18.9% of eligible infants born 
at study sites and 9.4% of the national VPT population. 
Our study sample was representative of the national VPT 
population in gestational age, birth weight, proportion 
of boys, singleton pregnancies, spontaneous onset of 
preterm labour and mode of delivery (table 1).
dnA extraction and quality
DNA was extracted from a subset of blood samples from 
521 full parent–infant trios who had successful linkage 
to infant clinical data. Of these, nine trios were excluded 
from genotyping due to inadequate DNA sample concen-
tration (below 50 ng/μL) of one of the trio members. An 
additional two trios were excluded due to array capacity, 
resulting in 510 (97.9%) trios of this subset being success-
fully genotyped.
Follow-up
Of the 883 infants whose parents consented to participate 
in the study, 796 (90.1%) agreed for their child’s future 
health and educational data to be linked to the research 
data. Consent was also obtained from the parents of 794 
(89.9%) for future direct contact.
diSCuSSion
Large- scale prospective cohort studies are time- 
consuming and expensive to conduct. Cohorts of special 
patient or high- risk groups, such as preterm infants, 
require assembly from multiple centres across large 
geographical areas, which poses additional logistical 
challenge. In our pilot study, we overcame some of these 
barriers by optimising research operational efficiencies. 
Although other large- scale preterm neonatal cohorts 
with genetic data exist internationally,13–17 none have 
collected parent DNA samples for trio- based genetic 
analyses. Parent blood samples for trio- based analysis 
are essential to identify likely pathogenic de novo vari-
ants. Our study approaches were purposefully designed 
to reduce research burden, respectful of the needs of 
preterm neonates and their families and sensitive to the 
culture within neonatal units. Within 1 year, we success-
fully established a large contemporaneous VPT neonatal 
cohort for genetic investigations.
Choice of recruitment and data collection methods
The completeness and quality of data held in the NNRD 
has been validated for use in research.18 The advantages 
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Figure 1 Flowchart of recruitment and establishment of the cohort for the Study of Preterm Infants and Neurodevelopmental 
Genes, England, UK, 2017–2018. VPT, very preterm.
of leveraging routine electronic health records for 
research are well- recognised. These include less intrusive 
data collection, elimination of the need for duplicate 
data entry and reduced research burden and cost. The 
reduced demands allowed us to incorporate the study 
activities within the workload of existing clinical and 
research staff at the participating centres, thereby mini-
mising research costs.
As no research- specific prospective data collection was 
required, our study design also removed the time pres-
sure to recruit newborn infants immediately after birth, 
particularly as this may be a stressful and emotional time 
for parents. Time constraints on decision- making reduce 
willingness to participate.19 Participants in our study were 
usually recruited a few weeks after delivery, when the 
parents had become more familiar with the neonatal unit 
environment and the clinical staff.
Another strategy we adopted was to use opportu-
nistic blood sampling for the infant. An aim of neonatal 
research is to minimise painful interventions and blood 
loss. Our approach removed the need for research- 
specific venepuncture and allowed sampling to be 
conducted flexibly.
limitations of study design
It was not possible to evaluate if our study design had 
a direct impact on recruitment rates as recruitment to 
neonatal studies varies widely depending on the nature 
of the study and the target population. Enrolment rates 
of more than 90% were achieved by population- based 
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Table 1 Neonatal characteristics of SPRING participants 
and of all VPT infants born in the participating/study sites 
and in England during the recruitment period (May 2017–
June 2018)
SPRING 
participants
(n=848)
All eligible 
infants born 
in study 
sites
(n=4491)
National 
cohort
(n=8998)
Gestational 
age in weeks, 
median (IQR)
28.9
(26–30)
29
(27–30)
29
(27–30)
Birth weight in 
grams, median 
(IQR)
1120
(886–1420)
1175
(882–1480)
1170
(880–1470)
Boys, n (%) 456 (53.8) 2469 (55.0) 4900 (54.5)
Singleton 
pregnancy, n 
(%)
638 (75.2) 3359 (74.8) 6706 (74.5)
Spontaneous 
onset of labour, 
n (%)
474 (55.9) 2431 (54.1) 4815 (53.5)
Caesarean 
section 
delivery, n (%)
498 (58.7) 2584 (57.5) 5087 (56.5)
Maternal age 
at birth in 
years,
median (IQR)
31 (27–35) Information 
not available
Information 
not available
SPRING, study of preterm infants and neurodevelopmental genes; 
VPT, very preterm.
preterm birth cohorts using traditional study methods 
such as the EPIPAGE 2,20 the EPICure 221 and the 
Express.22 This suggests that parents of preterm infants 
are in general willing to participate in birth cohort 
studies. However, it is recognised that genetic research 
studies typically experience lower recruitment rates than 
other types of biomedical research.23 Our enrolment 
rate (42.7% of parents approached) is comparable to 
that reported by the German Neonatal Network, which 
sought to collect DNA samples from very low birthweight 
(<1500 g) infants at 54 German NICUs and successfully 
enrolled 54% of eligible infants in the first 2 years.24 As 
our study relied entirely on existing neonatal staff, it 
was possible that recruitment was reduced by competing 
workloads. Staffing availability and research capacity 
across the study centres were highly variable. This had a 
measureable impact on the implementation of the study 
with approximately one- third of participating neonatal 
units only initiating recruitment mid- way through the 
recruitment phase. Despite this, we managed to achieve 
our recruitment target of 500 families within 11 months, 
ahead of schedule. We did not include the recruitment of 
a ‘term control group’, which will be vital for direct case–
control comparison, in this pilot study. The recruitment 
of well, term- born infants and their parents for genetic 
analyses will undoubtedly lend new logistical and ethical 
challenges that need further exploration.
Although our cohort was representative of the national 
VPT population in neonatal characteristics, selection 
bias might have been introduced due to the lack of study 
information materials adapted for non- English speaking 
families and for those with low literacy. Ethnic and socio-
economic disparities in preterm birth rates are well- 
described. Future studies should consider how to better 
integrate study processes targeted at enabling participa-
tion of these groups.
Although the NNRD has been successfully utilised for 
clinical research in the UK, the utility of the database 
for the study of environmental influences and outcome 
phenotyping in the context of genetic investigations has 
yet to be demonstrated, and will need to be examined 
in future studies. We had not allowed for the collection 
of different biological tissues at different time points 
to enable epigenetic analyses, as this would have added 
onto the research burden of the clinical teams and the 
families participating. The feasibility and acceptability of 
using archived or surplus biological specimens collected 
during routine clinical care, for example archived 
newborn blood spot, for this purpose could be further 
explored.
Acceptability of research by data linkage
The increasing availability of electronic health records 
and administrative data provides opportunity for longi-
tudinal cohort follow- up by data linkage. Traditional 
methods used in neonatal follow- up studies can be time- 
consuming, expensive and burdensome and are particu-
larly problematic for large sample sizes. In addition, 
follow- up studies are often compromised by selection 
bias due to attrition. We found a high level of willingness 
among parents for their child’s routine data to be used in 
neonatal follow- up research. This corroborates the find-
ings from a systematic review that reported widespread 
public support for data sharing and linkage for research 
purposes.25 In our study, we sought broad consent without 
specifying the time and type of data that will be accessed. 
However, Audrey et al revealed the complexity of issues 
surrounding informed consent for data linkage in a large 
qualitative study of young people’s views.26 Four hypo-
thetical scenarios were presented to 55 participants to 
prompt considerations regarding consent requirements. 
The authors concluded that perceptions were diverse, 
and sometimes inconsistent. In general, participant views 
on data linkage were influenced by the social sensitivity 
of the research question and the likely health benefits in 
the public interest. Future research in data linkage will 
benefit from a robust and consistent governance frame-
work that is acceptable to the public.
ConCluSionS
We demonstrate the feasibility of a streamlined study 
approach to achieve a large prospective VPT cohort 
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for clinical and genetic studies and the acceptability of 
follow- up through data linkage and recall. Our initial 
cohort is an important resource for studies of genetic 
risks and preterm birth, and longitudinal health and 
educational outcomes; our planned larger cohort will 
amplify this resource. The strategies described provide 
a template for future cost- effective and efficient cohort 
development.
Twitter Hilary S Wong @hilaryswong
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